In the swiftly evolving industry of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for acquiring helpful treatment options. Probably the most promising approaches is the use of in vitro bystander effect assays, which Participate in a pivotal role in enhancing therapeutic efficacy. Th